Healthcare - Biotechnology - NASDAQ - US
$ 15.8679
-0.202 %
$ 21 M
Market Cap
-0.83
P/E
CASH FLOW STATEMENT
-53.8 M
OPERATING CASH FLOW
12 M
INVESTING CASH FLOW
19.8 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Pieris Pharmaceuticals, Inc.
| Net Income | -24.5 M |
| Depreciation & Amortization | 1.78 M |
| Capital Expenditures | -171 K |
| Stock-Based Compensation | 3.35 M |
| Change in Working Capital | -7.38 M |
| Others | -34.4 M |
| Free Cash Flow | -54 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (24.5) | (33.3) | (45.7) | (37.2) | (25.5) | (26.8) | (17.6) | (22.8) | (14.1) | (9.8) | 66.2 K | (2.3) |
| Depreciation & Amortization | 1.8 | 2.8 | 2.4 | 2.1 | 1.0 | 0.6 | 0.4 | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 |
| Deferred Income Tax | (4.5) | 0 | 0 | 0.2 | (1.2) | (0.2) | 0.2 | (1.9) | 0 | 0.7 | 0 | 0 |
| Stock Based Compensation | 3.3 | 4.4 | 5.2 | 5.1 | 5.4 | 4.9 | 3.0 | 1.9 | 1.2 | 0.6 | 0 | 0 |
| Other Operating Activities | (22.5) | (0.5) | 30 K | 0.3 | 69 K | (1.6) | 0.3 | 1.9 | 0.7 | 2.6 | 0.4 | (7.1) |
| Change in Working Capital | (7.4) | (33.4) | 30.5 | (16.4) | (32.1) | 21.9 | 63.5 | 6.1 | (0.8) | 0.6 | (3.9) | (0.1) |
| Cash From Operations | (53.8) | (59.9) | (7.7) | (45.9) | (52.5) | (1.1) | 49.8 | (14.4) | (12.7) | (5.1) | (3.1) | (9.1) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (0.2) | (1.0) | (0.9) | (2.7) | (2.5) | (1.7) | (1.9) | (0.6) | (0.6) | (0.3) | 49.5 K | (0.1) |
| Other Items | 12.2 | (20.2) | 0 | 41.9 | 12.3 | (7.2) | (43.9) | 21 K | 0 | 0 | 0 | 90 |
| Cash From Investing Activities | 12.0 | (21.2) | (0.9) | 39.2 | 9.8 | (8.9) | (45.9) | (0.6) | (0.6) | (0.3) | 49.5 K | (0.1) |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (1.2) | 1.0 | 0.3 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 19.8 | 0.3 | 2.0 | 0.5 | 1.2 | 1.3 | 4.1 | 21 | 10 K | 7.3 | 0 | 2.3 |
| Cash From Financing Activities | 19.8 | 7.2 | 59.1 | 10.1 | 32.2 | 48.5 | 4.1 | 15.2 | 24.6 | 20.3 | 0.3 | 2.3 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | (21.2) | (79.1) | 47.3 | 8.2 | (12.6) | 37.0 | 8.5 | 6.4 K | 10.9 | 14.8 | (2.6) | (6.9) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (54.0) | (61.0) | (8.6) | (48.6) | (54.9) | (2.8) | 47.8 | (15.0) | (13.3) | (5.3) | (3.1) | (9.2) |